Sexual Dysfunctions, Psychological
34
2
3
25
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
13 trials with published results (38%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
11.8%
4 terminated out of 34 trials
86.2%
-0.3% vs benchmark
41%
14 trials in Phase 3/4
52%
13 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (34)
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
Early Psychological Intervention After Rape
Effects of Kegel Ball and Pelvic Floor Exercises on Sexual Function, Unrınary Incontinence and Quality of Life in Women
Sexual Health of Women With Genital Mutilation Seen at the Saint-Denis Women's Center
Mindfulness as Treatment of Sexological Problems
Internet-based Emotion Regulation Intervention for Sexual Health
Quality of Sexual Function in BRCA Mutated Women
Sexual Function Changes in High-Risk Pregnancies
Innovations in the Treatment of Sexual Health Post Prostate Cancer Treatment: Comparing Mindfulness vs. CBT
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder
HIV Prevention Among Vulnerable Male Youth
Study of Pharmacological Treatment in Women With Female Sexual Interest/Arousal Disorder (FSIAD).
Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men
Consistency of Questionnaires to Evaluating Sexual Functions in Young Healthy Women
Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties
12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress
24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA